Get the Stockscreener App
235.00
0.24%
-0.57
After Hours:
235.00
Overview
News
Price History
Option Chain
Financials
Why DHR Down?
Discussions
Forecast
Stock Split
Dividend History
Danaher Corp stock is traded at $235.00, with a volume of 2.53M.
It is down -0.24% in the last 24 hours and up +4.69% over the past month.
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
See More
Previous Close:
$235.57
Open:
$233.55
24h Volume:
2.53M
Relative Volume:
0.72
Market Cap:
$165.99B
Revenue:
$24.27B
Net Income/Loss:
$3.50B
P/E Ratio:
48.36
EPS:
4.8589
Net Cash Flow:
$5.02B
1W Performance:
+2.66%
1M Performance:
+4.69%
6M Performance:
+17.10%
1Y Performance:
-1.30%
1-Day Range:
$233.32
$237.70
1-Week Range:
$227.23
$240.44
52-Week Range:
$171.00
$258.23
Danaher Corp Stock (DHR) Company Profile
Name
Danaher Corp
Sector
Industry
Phone
(202) 828-0850
Address
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Compare DHR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
235.00 | 166.39B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
TMO
Thermo Fisher Scientific Inc
|
606.50 | 231.87B | 43.74B | 6.58B | 6.11B | 17.31 |
|
IDXX
Idexx Laboratories Inc
|
712.39 | 57.06B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
243.19 | 41.60B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
145.76 | 41.90B | 6.95B | 1.30B | 1.15B | 4.5696 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-02-25 | Initiated | Morgan Stanley | Overweight |
| Oct-08-25 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Jul-11-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Apr-10-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-21-25 | Upgrade | Goldman | Neutral → Buy |
| Mar-14-25 | Upgrade | Stifel | Hold → Buy |
| Feb-03-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-31-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Apr-17-24 | Upgrade | HSBC Securities | Hold → Buy |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-18-23 | Initiated | HSBC Securities | Hold |
| Dec-13-23 | Resumed | Wolfe Research | Peer Perform |
| Dec-07-23 | Downgrade | Goldman | Buy → Neutral |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-01-23 | Initiated | SVB Securities | Outperform |
| Apr-26-23 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-18-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-05-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Oct-24-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Aug-17-22 | Resumed | Bernstein | Outperform |
| Jul-20-22 | Initiated | UBS | Buy |
| Jun-01-22 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-11-22 | Initiated | Bernstein | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Sep-10-21 | Reiterated | BofA Securities | Buy |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-23-21 | Reiterated | Goldman | Buy |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Apr-07-21 | Resumed | Robert W. Baird | Outperform |
| Mar-03-21 | Resumed | Barclays | Overweight |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-25-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-16-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Apr-02-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Mar-26-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-03-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Resumed | Stifel | Hold |
| Oct-28-19 | Reiterated | Needham | Buy |
| Oct-14-19 | Resumed | Credit Suisse | Outperform |
| Jul-19-19 | Reiterated | Needham | Buy |
| Jun-11-19 | Initiated | Piper Jaffray | Neutral |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| Apr-17-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Reiterated | Needham | Buy |
| Feb-25-19 | Upgrade | Janney | Neutral → Buy |
| Jan-03-19 | Initiated | Needham | Buy |
| Apr-20-18 | Reiterated | Stifel | Buy |
View All
Danaher Corp Stock (DHR) Latest News
Danaher Corp. Stock: Silent Monster Move Or Overhyped Snoozefest? - AD HOC NEWS
Buy Danaher Stock. It’s Ready to Put Post-Covid Malaise Behind It. - Barron's
Robeco Institutional Asset Management B.V. Increases Stock Holdings in Danaher Corporation $DHR - MarketBeat
Cerity Partners LLC Lowers Holdings in Danaher Corporation $DHR - MarketBeat
Danaher Corporation (NYSE:DHR) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Danaher stock slips as analysts lift targets ahead of JPM Healthcare Conference, earnings - TechStock²
$1000 Placed in Danaher a Decade Ago Would Be Valued at This Amount Now - Bitget
Where Danaher Stands With Analysts - Benzinga
DHR: TD Cowen Raises Price Target to $270, Maintains "Buy" Ratin - GuruFocus
What insider purchases suggest about Danaher Corporation stockInstitutional Buying Trends & Ride the Trends That Billionaires Follow - ulpravda.ru
Danaher Corporation $DHR Shares Sold by Sivik Global Healthcare LLC - MarketBeat
Here's What to Expect From Danaher's Next Earnings Report - Barchart.com
Is Danaher (DHR) Pricing In Too Much Optimism After Recent Steady Share Performance - Yahoo Finance
Biotech Stocks To Watch TodayJanuary 3rd - MarketBeat
Assessing Danaher (DHR) Valuation As The Business Refocuses On Life Sciences And Diagnostics - simplywall.st
Greenleaf Trust Has $15.47 Million Stock Holdings in Danaher Corporation $DHR - MarketBeat
Top Biotech Stocks To Watch NowJanuary 2nd - MarketBeat
Danaher to Present at J.P. Morgan Healthcare Conference - Yahoo Finance
Guggenheim Raises Price Target on DHR to $275, Maintains Buy Rat - GuruFocus
Panic Selling: Is Danaher Corporation stock a defensive play in 2025July 2025 Price Swings & Verified High Yield Trade Plans - moha.gov.vn
Danaher’s Push Into Higher‑Margin Life Sciences Might Change The Case For Investing In DHR - simplywall.st
Railway Pension Investments Ltd Boosts Stake in Danaher Corporation $DHR - MarketBeat
Danaher Corporation (DHR) Stock Analysis: Evaluating a Strong Buy with 12.51% Upside Potential - DirectorsTalk Interviews
Promising Biotech Stocks To ConsiderJanuary 4th - MarketBeat
Danaher Corporation $DHR Stake Boosted by Capital Advisors Inc. OK - MarketBeat
Best sustainable companies to own in 2026 - Morningstar Australia
Danaher Corp Is Quietly Eating Wall Street — Are You Sleeping On DHR? - AD HOC NEWS
Guggenheim Boosts Danaher (NYSE:DHR) Price Target to $275.00 - MarketBeat
JARISLOWSKY FRASER Ltd Lowers Stake in Danaher Corporation $DHR - MarketBeat
GAM Holding AG Acquires 9,081 Shares of Danaher Corporation $DHR - MarketBeat
Altfest L J & Co. Inc. Sells 5,124 Shares of Danaher Corporation $DHR - MarketBeat
Bioprocess Filtration Global Markets Report 2025-2030, Profiles of Leading PlayersDanaher, Merck, Sartorius, Solventum, and RepligenResearchAndMarkets.com - FinancialContent
Single-Use Bioprocessing Products Market Set to Reach USD 36 - openPR.com
Bank Pictet & Cie Europe AG Increases Holdings in Danaher Corporation $DHR - MarketBeat
Ascent Group LLC Acquires 5,422 Shares of Danaher Corporation $DHR - MarketBeat
Vanderbilt University Takes Position in Danaher Corporation $DHR - MarketBeat
Allspring Global Investments Holdings LLC Raises Stock Holdings in Danaher Corporation $DHR - MarketBeat
Best Biotech Stocks To ConsiderDecember 29th - MarketBeat
Fortive Corp.: The Quiet Infrastructure Platform Powering the Next Industrial Upgrade - AD HOC NEWS
Danaher stock in focus: defensive quality meets cautious optimism as Wall Street updates its targets - AD HOC NEWS
Strength in Medical & Fluid Solutions Unit Drives Nordson: Can It Sustain? - TradingView — Track All Markets
Meridian Financial Partners LLC Takes $896,000 Position in Danaher Corporation $DHR - MarketBeat
Calamos Wealth Management LLC Has $16.98 Million Stake in Danaher Corporation $DHR - MarketBeat
Calamos Advisors LLC Sells 36,163 Shares of Danaher Corporation $DHR - MarketBeat
Best Biotech Stocks To Follow NowDecember 28th - MarketBeat
The Truth About Danaher Corp: Hidden Giant Every Investor Keeps Sleeping On - AD HOC NEWS
Biotech Stocks To ConsiderDecember 27th - MarketBeat
Simplify Asset Management Inc. Sells 10,166 Shares of Danaher Corporation $DHR - MarketBeat
Mirova US LLC Cuts Holdings in Danaher Corporation $DHR - MarketBeat
Danaher Stock in Focus: Subtle Pullback, Strong Underlying Story - AD HOC NEWS
Cwm LLC Acquires 10,580 Shares of Danaher Corporation $DHR - MarketBeat
Danaher Corp Stock (DHR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):